All In Biotech

Drug Trial Radar · NCT04811560

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) Inhibitor Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

420

Planned (sponsor's estimate)

Start

May 19, 2021

Primary completion

Dec 29, 2028

Study completion Sep 22, 2030

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Mar 23, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of bleximenib in phase 1 Part 1 (Dose Escalation) and to determine the safety and tolerability at RP2D in Phase 1 Part 2 (Dose expansion). The purpose of the Phase 2 part of the study is to evaluate the efficacy of bleximenib at the RP2D.

Conditions

  • Acute Leukemia

Interventions

  • BleximenibDrug

    Bleximenib is administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 1: Number of Participants with Adverse Events (AEs) as a Measure of Safety and TolerabilityTime frame: Up to 4 years and 9 months
  2. Phase 1: Number of Participants with AEs by SeverityTime frame: Up to 4 years and 9 months
  3. Phase 1: Part 1: Percentage of Participants with Dose-Limiting Toxicity (DLT)Time frame: Up to 28 days Cycle 1
  4. Phase 2: Rate of Complete Remission or Complete Remission with Partial Hematologic Recovery (CR/CRh)Time frame: Up to 4 years and 9 months

Locations

102 sites in 13 countries. Site status is shown where the registry gives one.

  • City of Hope

    Duarte, California · Recruiting

  • University of California Irvine Medical Center

    Orange, California · Completed

  • University of California San Francisco

    San Francisco, California · Recruiting

  • UCSF Benioff Children's Hospital

    San Francisco, California · Recruiting

  • University of Chicago

    Chicago, Illinois · Recruiting

  • St Francis Hospital & Health Centers Indiana Blood and Marrow Transplantation

    Indianapolis, Indiana · Recruiting

  • Norton Cancer Institute

    Louisville, Kentucky · Completed

  • Maine Health

    South Portland, Maine · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Dana Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • Karmanos Cancer Institute

    Detroit, Michigan · Completed

  • Start Midwest

    Grand Rapids, Michigan · Recruiting

  • University of New Mexico

    Albuquerque, New Mexico · Recruiting

  • Roswell Park Comprehensive Cancer Center

    Buffalo, New York · Recruiting

  • NYU Langone Medical Center

    New York, New York · Recruiting

  • Montefiore Medical Center

    The Bronx, New York · Recruiting

  • Oregon Health And Science University

    Portland, Oregon · Recruiting

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania · Completed

  • University of Tennessee Medical Center

    Knoxville, Tennessee · Recruiting

  • Baylor University Medical Center

    Dallas, Texas · Recruiting

  • Houston Methodist Hospital

    Houston, Texas · Recruiting

  • MD Anderson

    Houston, Texas · Recruiting

  • San Antonio Methodist TX Transplant Physicians Group

    San Antonio, Texas · Recruiting

  • Virginia Commonwealth University

    Richmond, Virginia · Recruiting

  • Swedish Cancer Institute

    Seattle, Washington · Recruiting

  • Medical College of WI at Froedtert

    Milwaukee, Wisconsin · Recruiting

  • Monash Medical Centre

    Clayton, Australia · Recruiting

  • Royal Perth Hospital

    Perth, Australia · Recruiting

  • Gold Coast University Hospital

    Southport, Australia · Recruiting

  • Ghent University Hospital

    Ghent, Belgium · Recruiting

  • IDOR - Regional Brasilia

    Brasília, Brazil · Recruiting

  • Liga Norte Riograndense Contra O Cancer

    Natal, Brazil · Recruiting

  • Ministerio da Saude Instituto Nacional do Cancer

    Rio de Janeiro, Brazil · Recruiting

  • Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo

    São Paulo, Brazil · Recruiting

  • IDOR - Regional Sao Paulo

    São Paulo, Brazil · Recruiting

  • Fundacao Antonio Prudente A C Camargo Cancer Center

    São Paulo, Brazil · Recruiting

  • Vancouver Coastal Health

    Vancouver, British Columbia, Canada · Recruiting

  • Princess Margaret Cancer Centre University Health Network

    Toronto, Ontario, Canada · Recruiting

  • Hopital Maisonneuve Rosemont

    Montreal, Quebec, Canada · Recruiting

  • Peking University First Hospital

    Beijing, China · Recruiting

Showing 40 of 102 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.